DI
LRMR icon

Disciplined Investments’s Larimar Therapeutics LRMR Stock Holding History

Disciplined Investments’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-116
Closed -$363 – 926
2023
Q2 		$363 Hold
116
– – ﹤0.01% 1340
2023
Q1 		$526 Hold
116
– – ﹤0.01% 1209
2022
Q4 		$480 Hold
116
– – ﹤0.01% 1198
2022
Q3 		$0 Hold
116
– – ﹤0.01% 1436
2022
Q2 		$0 Hold
116
– – ﹤0.01% 1470
2022
Q1 		$0 Hold
116
– – ﹤0.01% 1499
2021
Q4 		$1K Hold
116
– – ﹤0.01% 474
2021
Q3 		$1K Hold
116
– – ﹤0.01% 425
2021
Q2 		$1K Buy
+116
New +$1.31K ﹤0.01% 408

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Disciplined Investments's LRMR Position: Q3 2023 in Review

Disciplined Investments sold out of Larimar Therapeutics (LRMR) in Q3 2023, closing a stake of 116 shares — an estimated $363 sold.

Disciplined Investments first reported a position in LRMR in Q2 2021 and held it in 9 quarters. The position peaked at $1K in Q4 2021. 65 funds tracked by Wall St. Rank hold LRMR as of Q3 2023.

  • Disciplined Investments reported no remaining Larimar Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 116 Larimar Therapeutics shares in Q3 2023, an estimated $363.
  • Disciplined Investments first reported a position in Larimar Therapeutics in Q2 2021 and held it in 9 quarters.
  • Disciplined Investments's Larimar Therapeutics position peaked at $1K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.